Journal of Patient Care

Impact of Chronic Non-Communicable Diseases

David Bloom^* Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
^*Correspondence: David Bloom, Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, Email:

Received: 29-Jun-2022, Manuscript No. JPC-22-17728; Editor assigned: 04-Jul-2022, Pre QC No. JPC-22-17728(PQ); Reviewed: 21-Jul-2022, QC No. JPC-22-17728; Revised: 26-Jul-2022, Manuscript No. JPC-22-17728(R); Published: 04-Aug-2022, DOI: 10.35248/2573-4598.22.8.195

Description

Nearly 70% of all fatalities globally are caused by Non- Communicable Diseases (NCDs), which include chronic lung disease, cancer, diabetes, and heart disease. Nearly 75% of all NCD deaths and 82% of the 16 million persons who passed away before turning 70 years old take place in low- and middleincome nations. Four main risk factors tobacco use, physical inactivity, hazardous alcohol use, and poor diet have mostly been responsible for the growth of NCDs.

The NCD epidemic threatens to overburden healthcare systems and has terrible health effects on people, families, and communities. The prevention and control of these diseases are a critical development imperative for the 21^st century due to the socioeconomic implications associated with NCDs. The NCD epidemic threatens to overburden healthcare systems and has terrible health effects on people, families, and communities [1].

The goal of WHO is to give direction and a solid evidence base for global action on NCD surveillance, prevention, and control. To lessen the burden of NCDs, the government must take immediate action. Noncommunicable Diseases (NCDs) can significantly harm both individual financial stability and the expansion of the national economy. The most productive years of a person's life are frequently affected by NCDs in low- and middle-income nations. Households suffer with higher financial risk when people with NCDs must pay high healthcare expenditures and have limited employment options [2]. The high cost of healthcare and decreased productivity put a pressure on emerging nations’ economies and obstructs social and economic progress.

Chronic disease is a challenging and expanding health issue [3]. The World Health Organization (WHO) estimates that Noncommunicable diseases like cancer, chronic lung disease, diabetes, and heart disease caused 71% of all deaths worldwide in 2016. Developing nations with low and moderate incomes are bearing an excessive burden. According to the WHO, they caused more than 75% of NCD deaths in 2016. Additionally, these diseases have a huge economic impact on the world. The World Economic Forum estimates that by 2030, treating NCDs will cost the global economy $30 trillion.

That is money that cannot be used for other purposes, such as infrastructure and education projects, which are essential for reaching the Sustainable Development Goals of the United Nations, which aspire to break the cycles of poverty and inequality [4]. Additionally, NCDs have a significant negative influence on one's own health, lowering the quality of life for those who suffer from chronic illnesses as well as their loved ones and caregivers.

Think about experiencing a heart attack. Your situation requires immediate medical attention, and even with the best treatment, some heart attacks necessitate a protracted period of recovery and rehabilitation. You take off weeks of work to heal. You might need a friend or family member to take some time off to assist you in getting back on your feet. Particularly if you are unable to resume the full level of active life you had prior to your heart attack, the financial and emotional toll can be devastating and put you and your family or caretakers financially behind for years. Millions of unnecessary deaths and billions in economic losses could be avoided by investing in NCD prevention and control techniques [5].

Countries can develop effective programs and policies by studying the economic effects of NCDs and NCD treatments. The CDC works along with partners to encourage the financial analysis of NCD initiatives like the hearts strategy external symbol for CVD prevention in primary care. Expand the study of NCD economics in science. Make tools to assess the expenses of NCDs. Teach economic analysis and evaluation to international partners.

Use data to guide the creation of NCD strategies. A global alliance of academic, governmental, and non-profit researchers known as the International NCD Economics Research Network, which CDC also sponsors and co-chairs, conducts and disseminates peer-reviewed research on the effects of NCD prevention and control programs and policies.

Implementing multispectral policies to lower population-level hazards for NCDs and providing efficient and reasonably priced primary care therapies for individuals with chronic NCDs are necessary for reducing the burden of chronic NCDs. Common NCDs are frequently treated ineffectively and ineffectively by primary care. As a result, we suggest a programmatic, standardized approach to the provision of primary care therapies for patients with NCDs, with an emphasis on obesity, chronic airflow obstruction, diabetes mellitus, hypertension, and mellitus. Patients with associated diseases, such as those with chronic renal disease brought on by diabetes or hypertension will also benefit from this strategy. This "public health approach" concept is based on knowledge gained from scaling up therapies for chronic infectious illnesses (tuberculosis and HIV).

The necessity of acquiring political commitment, creating a solid strategy, delivering standardized interventions, and maintaining strict monitoring and evaluation of progress towards stated targets are only a few of the lessons learned from the progress in rolling out these interventions. Through a primary care strategy with three components, the framework seeks to lessen the burden of sickness, disability, and early mortality associated with NCDs. Screening for common NCDs, identifying and addressing modifiable risk factors, and diagnosing, treating, and monitoring individuals with common NCDs are the first three steps. The proposed framework for NCDs includes similar components to those created for the control of tuberculosis, including a goal, strategy, and targets for NCD control, a package of interventions for quality care, key operations for national implementation of these interventions (political commitment, case-finding among those using primary care services, standardized diagnostic and treatment protocols, regular drug supply, systematic monitoring and evaluation), and indicators for the effectiveness of these interventions. The system requires assessment, followed by adaption in various contexts.

REFERENCES

1. Ghaffar A, Hyder AA. Road traffic injuries, health and development-the new challenge for public health systems in South Asia. J Coll Physicians Surg Pak. 2004; 14(12):704.

   [Google Scholar] [Pubmed]

2. Ghaffar A, Hyder AA, Masud TI. The burden of road traffic injuries in developing countries: the 1st national injury survey of Pakistan. Public Health. 2004; 118(3):211-217.

   [Crossref] [Google Scholar] [Pubmed]

3. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth M. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989; 298(6673):564-567.

   [Crossref] [Google Scholar] [Pubmed]

4. Rahim HF, Sibai A, Khader Y, Hwalla N, Fadhil I, Alsiyabi H. Non-communicable diseases in the Arab world. Lancet. 2014; 383(9914):356-367.

   [Crossref] [Google Scholar] [Pubmed]

5. Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006; 100(3):191-199.

   [Crossref] [Google Scholar] [Pubmed]